NCT05193071View on ClinicalTrials.gov

Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,022

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

October 25, 2024

Study Completion Date

October 25, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Aspirin 100mg; Clopidogrel 300mg

Aspirin 100mg plus Clopidogrel 300mg will be orally administrated after randomization

Trial Locations (2)

110016

Department of Neurology, General Hospital of Northern Theater Command, Shenyang

110840

Hui-sheng Chen, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER